Therapeutic peptides increase in trials, Tufts study finds

05/21/2009 | Boston Globe (tiered subscription model), The

The Tufts Center for the Study of Drug Development found that the average annual number of therapeutic peptides used in clinical trials increased from 9.7 during the 1990s to 16.9 between 2000 and 2007. "Therapeutic peptides have emerged as a therapeutically and commercially important class of drugs, and 48 are now on the market worldwide, with four having generated global sales of more than $500 million each in 2007," the study author said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX